Posted inConsumer News, Featured, Medicare, Prescription Drugs

Drug Industry Lobbyists & Campaign Cash Stymie Bid to Restrain Medicare Drug Costs

North Carolina Sen. Richard Burr is the top recipient of pharmaceutical industry lobbying contributions in Congress. By Stuart Silverstein FairWarning When the Republican-controlled Congress approved a landmark program in 2003 to help seniors buy prescription drugs, it slapped on an unusual restriction: The federal government was barred from negotiating cheaper prices for those medicines. Instead, […]